首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   319008篇
  免费   31653篇
  国内免费   23297篇
耳鼻咽喉   2713篇
儿科学   3465篇
妇产科学   3696篇
基础医学   38420篇
口腔科学   5564篇
临床医学   44384篇
内科学   43792篇
皮肤病学   3708篇
神经病学   16792篇
特种医学   12303篇
外国民族医学   212篇
外科学   29956篇
综合类   56169篇
现状与发展   90篇
一般理论   31篇
预防医学   21019篇
眼科学   9372篇
药学   35353篇
  361篇
中国医学   19984篇
肿瘤学   26574篇
  2024年   371篇
  2023年   4602篇
  2022年   7583篇
  2021年   14643篇
  2020年   12804篇
  2019年   11007篇
  2018年   11499篇
  2017年   10559篇
  2016年   9997篇
  2015年   15234篇
  2014年   18943篇
  2013年   16840篇
  2012年   24882篇
  2011年   27850篇
  2010年   17859篇
  2009年   14138篇
  2008年   17895篇
  2007年   17595篇
  2006年   17634篇
  2005年   17134篇
  2004年   10623篇
  2003年   9680篇
  2002年   8118篇
  2001年   6796篇
  2000年   7263篇
  1999年   7767篇
  1998年   4944篇
  1997年   5006篇
  1996年   3821篇
  1995年   3727篇
  1994年   3083篇
  1993年   2062篇
  1992年   2336篇
  1991年   1954篇
  1990年   1646篇
  1989年   1382篇
  1988年   1184篇
  1987年   992篇
  1986年   767篇
  1985年   627篇
  1984年   369篇
  1983年   225篇
  1982年   123篇
  1981年   133篇
  1980年   90篇
  1979年   100篇
  1974年   7篇
  1972年   8篇
  1939年   6篇
  1937年   5篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
51.
樊睿  张夏丽  代华灵  赵瑞玲 《中国药事》2022,36(11):1286-1294
目的:调查山西省146所设有儿科的医疗机构儿科药学服务现状及225名药师药学服务能力基本情况,研究目前山西省儿科药学服务存在的问题。方法:以“问卷星”的形式发放调查表,对山西省医疗机构儿科药学人员配备情况、硬件水平及药学服务能力水平等进行调查,并进行统计分析。结果:省内医疗机构未配备药学智能化设备占比53.42%,配备情况有待提高;儿科临床药师配备较少,仅占16.44%;受访医疗机构开展的药学服务在儿科患者用药交代、用药咨询及用药教育、处方(医嘱审核)、药学科普服务等方面占比较大,在开展儿童静脉药物集中调配、药学门诊、慢病管理及治疗药物监测(TDM)等药学服务占比较小,分别占比11.64%、10.27%、4.79%以及4.11%。结论:本次调查在一定程度上反映山西省目前医疗机构儿科药学服务存在的相关问题,药学服务水平需要整体提升,服务模式目前尚属于探索性阶段,需要逐渐模式化、规范化及统一化,为患者提供同质化的药学服务。  相似文献   
52.
ObjectiveTo evaluate the efficacy and safety of prompt phacoemulsification, intraocular lens implantation, visco-goniosynechialysis, combined with pseudo-pupilloplasty for refractory acute primary angle closure (APAC) with atonic dilated pupil and to describe a feasible method of pupilloplasty.MethodsA consecutive series of refractory APAC patients who had atonic dilated pupil and undergone prompt phacoemulsification combined with pseudo-pupilloplasty at our center were retrospectively analyzed. Pseudo-pupilloplasty referred to a method of pupilloplasty which included 4.5-mm capsulorhexis, postoperative opacification of anterior capsule residue, and ultimate pseudo-pupil formation. Preoperative and postoperative measurements included intraocular pressure (IOP), best corrected visual acuity (BCVA), and anterior chamber depth (ACD). Intraoperative and postoperative complications were documented. The process of pseudo-pupil formation was also observed.ResultsA total of 20 eyes of 19 APAC patients were followed up for 19.7 ± 9.8 months. IOP was lowered from preoperative 44.0 ± 9.8 mmHg to 15.5 ± 2.6 mmHg at final visit (t = 11.945, P < 0.001). ACD was deepened from preoperative 1.77 ± 0.21 mm to 3.40 ± 0.20 mm at final visit (t = –27.711, P < 0.001). Twelve of 20 eyes had residual angle synechiae, whereas only 3 eyes needed anti-glaucoma medications. No severe complication was observed. All eyes had pseudo-pupil gradually formed within 3 months, accompanied with the gradual improvement of BCVA from preoperative 1.18 ± 0.55 to 0.58 ± 0.22, 0.26 ± 0.09, 0.11 ± 0.09, and 0.11 ± 0.09 at postoperative day 1, month 1, month 3, and last visit.ConclusionsPrompt phacoemulsification-goniosynechialysis is effective and safe for refractory APAC with atonic dilated pupil. Pseudo-pupilloplasty is a feasible procedure for pupil reconstruction.  相似文献   
53.
A 2-year-old girl was diagnosed as Weill-Marchesani syndrome with typical systemic features of short stature, short and stubby hands and feet, language disorders and mental retardation. He developed bilateral angle closure glaucoma, ectopia lentis and suffered visual loss from the ocular features of Weill-Marchesani syndrome. The child was successfully treated by combined CO2 laser-assisted sclerectomy surgery and trabeculectomy.  相似文献   
54.
55.
随着压力性损伤的研究重心逐渐向细胞水平转移,发现力学因素下细胞结构和功能改变在压力性损伤发展过程中起重要作用。综述力学因素下压力性损伤发生机制、影响因素、评估以及预防管理。旨在提高护理人员对压力性损伤更为深入地认知,从而推动压力性损伤研究多元化发展。  相似文献   
56.
Cantharidin (CTD) is an effective antitumor agent. However, it exhibits significant hepatotoxicity, the mechanism of which remains unclear. In this study, biochemical and histopathological analyses complemented with ultra-high-performance liquid chromatography–tandem mass spectrometry (UHPLC-MS/MS)-based targeted metabolomic analysis of bile acids (BAs) were employed to investigate CTD-induced hepatotoxicity in rats. Sixteen male and female Sprague–Dawley rats were randomly divided into two groups: control and CTD (1.0 mg/kg) groups. Serum and liver samples were collected after 28 days of intervention. Biochemical, histopathological, and BA metabolomic analyses were performed for all samples. Further, the key biomarkers of CTD-induced hepatotoxicity were identified via multivariate and metabolic pathway analyses. In addition, metabolite–gene–enzyme network and Kyoto Encyclopedia of Genes and Genomes pathway analyses were used to identify the signaling pathways related to CTD-induced hepatotoxicity. The results revealed significantly increased levels of biochemical indices (alanine aminotransferase, aspartate aminotransferase, and total bile acid). Histopathological analysis revealed that the hepatocytes were damaged. Further, 20 endogenous BAs were quantitated via UHPLC-MS/MS, and multivariate and metabolic pathway analyses of BAs revealed that hyocholic acid, cholic acid, and chenodeoxycholic acid were the key biomarkers of CTD-induced hepatotoxicity. Meanwhile, primary and secondary BA biosynthesis and taurine and hypotaurine metabolism were found to be associated with the mechanism by which CTD induced hepatotoxicity in rats. This study provides useful insights for research on the mechanism of CTD-induced hepatotoxicity.  相似文献   
57.
International Ophthalmology - To evaluate and compare the accuracy of six different formulas (Emmetropia Verifying Optical version 2.0, Kane, SRK/T, Barrett Universal II, Haigis and Olsen) in...  相似文献   
58.
59.
60.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号